Brief: Chimeric Therapeutics Receives A$4.5M R&D Tax Incentive
24/11/2025 01:45
Nov 24 (Reuters) - Chimeric Therapeutics Ltd CHM.AX: CHIMERIC RECEIVES $4.5M RESEARCH AND DEVELOPMENT TAX INCENTIVE ALL FIGURES IN AUD Further company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial